CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +267,862 | 267,862 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +739 | 739 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +13,394 | 13,394 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +7,411 | 249,974 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +244 | 8,180 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +8,185 | 276,047 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +23 | 762 | ||
| 2014-05-16 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Warrants | +410 | 13,804 |
Page 20 of 20 · 388 trades